Don’t forget you can visit MyAlerts to manage your alerts at any time.
By Chris O'Malley | January 31, 2024
Jennifer Rhodes is taking the legal reins of the only company with a Food and Drug Administration-approved treatment for Parkinson's hallucinations.
2 minute read
By Lisa L. Smith, Eric M. Kraus and Julia M. Markov | January 29, 2024
On Dec. 12, 2023, MAPS PBC, now Lykos Therapeutics, announced their submission of a New Drug Application to the FDA for MDMA in combination with psychotherapy for the treatment of post-traumatic stress disorder.
7 minute read
By Emily Cousins | January 26, 2024
"We don't know, frankly, why they're dragging their feet," law school student Alex Johnson said.
4 minute read
By Brian Lee | January 23, 2024
Hospitals, nursing homes, medical schools and other healthcare and residential care providers, along with physician practice groups will need counsel on implementation of New York's latest version of the bill, said attorney Mary Beth Quaranta Morrissey.
5 minute read
By Gregg Goldfarb | January 22, 2024
Ozempic isn't without side effects, however, and several patients who have experienced severe complications from the drug are now suing Novo Nordisk and Eli Lilly on allegations that the pharmaceutical companies misled doctors on the drugs' potential risks.
5 minute read
By Vasilios J. Kalogredis | January 22, 2024
Because of the various avenues available, foreign health care workers should keep abreast of the different visa types; advantages, disadvantages, and eligibility for each; and the processes and timelines involved.
6 minute read
By Chris O'Malley | January 19, 2024
If Health and Human Services provides assistance, health care attorneys worry it also will stiffen the consequences for noncompliance.
5 minute read
By Patrick Smith | January 16, 2024
The lateral group, with a focus on FDA and regulatory compliance, will provide a boost to McDermott's health-care practice, particularly with M&A activity projected to pick up in 2024, the firm said.
2 minute read
By Jeanna M. Wacker, Tasha Gerasimow and Nick Johnston | January 12, 2024
This article highlights several notable legal and regulatory developments in 2023 and discusses developments that will continue to shape the pharmaceutical industry in 2024.
8 minute read
By Lisa Hayes, Chair, Health Law Section | January 11, 2024
Lisa Hayes, chair of the Health Law Section, writes: Changes to accreditation requirements, policy changes to abolish the race-based practice of medicine and expansion of innovative methods for service delivery to ensure racial justice will all work to impact the expanding role and responsibilities of health care attorneys.
3 minute read
Presented by BigVoodoo
The National Law Journal Elite Trial Lawyers recognizes U.S.-based law firms performing exemplary work on behalf of plaintiffs.
GlobeSt. Women of Influence Conference celebrates the women who drive the commercial real estate industry forward.
The New York Law Journal honors attorneys and judges who have made a remarkable difference in the legal profession in New York.
Cullen and Dykman is seeking an associate attorney with a minimum of 5+ years in insurance coverage experience as well as risk transfer and ...
McCarter & English, LLP is actively seeking a midlevel insurance coverage associate for its Newark, NJ and/or Philadelphia, PA offices. ...
McCarter & English, LLP, a well established and growing law firm, is actively seeking a talented and driven associate having 2-5 years o...